A heart attack is very rare under the age of 30 — in the order of about 2 men per 100,000 per year. But this number continues to increase throughout lifetime. (Women also get heart disease but at a ...

DEAR DR. ROACH: I’m always saddened when a young person dies of an old person’s calling. I read about an actor dying of a heart attack at age 57. Apparently, he was athletic and in otherwise good ...

Chronic stress may weaken the cardiovascular benefits of LDL-C-lowering therapy and sustain inflammation in ASCVD. Learn more from EAS 2026.

I encourage people to focus on those you can control—such as what you eat and how active you are—and do the best you can to ...

Every day, your liver assembles billions of tiny cholesterol-carrying particles and ships them into your blood. How many it ...

Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Avoid alcohol at least three hours before bedtime to prevent ...

A new LMU study shows how differently immune cells influence the formation of dangerous vascular deposits – and identifies miR-147 as a potential ...

A major new study suggests that people may benefit from lowering their cholesterol much earlier in life than doctors ...

VERVE-102 is an investigational gene-editing therapy designed to permanently turn off the PCSK9 gene in the liver to reduce ...

The VERVE-102 base editor appeared to be safe and reduce low-density lipoprotein cholesterol levels by up to 62 percent in a Phase I open-label, single-ascending dose trial.

Higher sensorimotor function was associated with reduced likelihood of mild cognitive impairment in two cohorts of older ...